Amneal Pharmaceuticals (AMRX) EV to EBITDA (2018 - 2026)
Amneal Pharmaceuticals' EV to EBITDA came in at 8.46 for Q2 2026, up 107.5% from 4.08 a year earlier and up 41.0% from the prior quarter.
Powered by 
Analysis
Amneal Pharmaceuticals (AMRX) EV to EBITDA (2018 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Amneal Pharmaceuticals reported EV to EBITDA of 7.41, up 101.0% year-over-year; for FY2025, it was 6.09, up 22.7% from FY2024.
- EV to EBITDA has increased in each of the last four years.
- Going back by year, EV to EBITDA was 4.96 in FY2024 (+18.9%), 4.17 in FY2023 (+0.5%), 4.15 in FY2022 (+32.1%) and 3.14 in FY2021 (-1.4%).
- The Q2 2026 figure represents the highest quarterly EV to EBITDA since Q2 2022.
- Year-over-year, EV to EBITDA has increased for three consecutive quarters, with growth averaging 33.6% over the last eight quarters.
- The fastest year-over-year change in EV to EBITDA over five years came in Q2 2022 (growth of 147.6%), and the weakest in Q2 2023 (a decline of 76.7%).
- Business Quant data shows AMRX's EV to EBITDA at 6.00 (Q1 2026), 6.09 (Q4 2025) and 5.04 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Amneal Pharmaceuticals | 6.55 Bn | 5.82 Bn | 334.51 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.46 |
| Mar 31, 2026 | 6.00 |
| Dec 31, 2025 | 6.09 |
| Sep 30, 2025 | 5.04 |
| Jun 30, 2025 | 4.08 |
| Mar 31, 2025 | 4.39 |
| Dec 31, 2024 | 4.96 |
| Sep 30, 2024 | 6.18 |
| Jun 30, 2024 | 4.94 |
| Mar 31, 2024 | 4.85 |
| Dec 31, 2023 | 4.17 |
| Sep 30, 2023 | 2.70 |
| Jun 30, 2023 | 2.01 |
| Mar 31, 2023 | 1.96 |
| Dec 31, 2022 | 4.15 |
| Sep 30, 2022 | 4.55 |
| Jun 30, 2022 | 8.63 |
| Mar 31, 2022 | 2.92 |
| Dec 31, 2021 | 3.14 |
| Sep 30, 2021 | 3.36 |
API Access
Amneal Pharmaceuticals EV to EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=AMRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-ebitda", "ticker": "AMRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=AMRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();